Decreased spatial frequency sensitivities for processing faces in male patients with chronic schizophrenia

2009 ◽  
Vol 120 (8) ◽  
pp. 1525-1533 ◽  
Author(s):  
Choji Obayashi ◽  
Taisuke Nakashima ◽  
Toshiaki Onitsuka ◽  
Toshihiko Maekawa ◽  
Yoji Hirano ◽  
...  
1994 ◽  
Vol 164 (2) ◽  
pp. 177-183 ◽  
Author(s):  
Simon M. Halstead ◽  
Thomas R. E. Barnes ◽  
Jeremy C. Speller

In a sample of 120 long-stay in-patients who fulfilled DSM–III–R criteria for schizophrenia, chronic akathisia and pseudoakathisia were relatively common, with prevalence figures of 24% and 18%, respectively. Compared with patients without evidence of chronic akathisia, those patients with the condition were significantly younger, were receiving significantly higher doses of antipsychotic medication, and were more likely to be receiving a depot antipsychotic. Patients who experienced the characteristic inner restlessness and compulsion to move of akathisia also reported marked symptoms of dysphoria, namely tension, panic, irritability and impatience. The findings support the suggestion that dysphoric mood is an important feature of akathisia. Male patients appeared to be at an increased risk of pseudoakathisia. No significant relation was found between chronic akathisia and tardive dyskinesia, although there was a trend for trunk and limb dyskinesia to be commonest in patients with chronic akathisia while orofacial dyskinesia was most frequently observed in those with pseudoakathisia. Akathisia may mask the movements of tardive dyskinesia in the lower limb. There was no evidence that akathisia was associated with positive or negative symptoms of schizophrenia nor with depression.


2020 ◽  
Vol 41 (10) ◽  
pp. 2762-2781 ◽  
Author(s):  
Cláudia Régio Brambilla ◽  
Tanja Veselinović ◽  
Ravichandran Rajkumar ◽  
Jörg Mauler ◽  
Linda Orth ◽  
...  

2020 ◽  
Vol 237 (11) ◽  
pp. 3409-3416
Author(s):  
Shuochi Wei ◽  
Dongmei Wang ◽  
Gaoxia Wei ◽  
Jiesi Wang ◽  
Huixia Zhou ◽  
...  

1961 ◽  
Vol 107 (448) ◽  
pp. 523-528 ◽  
Author(s):  
N. Gold

“A doctor must know not only the virtue of a drug, but also its drawbacks”—Carling (1960).Thioridazine is one of the newer phenothiazine derivatives used in psychiatry. Previous workers have reported few serious side-effects with it. The following pilot trial was carried out on male patients suffering from chronic schizophrenia who required nursing in a closed ward.


2012 ◽  
Vol 5 (1) ◽  
pp. 54-57 ◽  
Author(s):  
Zhiren Wang ◽  
Yunlong Tan ◽  
Fude Yang ◽  
Wufang Zhang ◽  
Yizhuang Zou ◽  
...  

1992 ◽  
Vol 160 (2) ◽  
pp. 253-256 ◽  
Author(s):  
Elizabeth J. B. Davis ◽  
Milind Borde ◽  
L. N. Sharma

Cognitive impairment, negative and positive symptoms, primitive release reflexes, and age/temporal disorientation were assessed in 20 male patients meeting the DSM–III–R criteria for chronic schizophrenia and Schooler & Kane's criteria for TD. The control group comprised 20 age-matched male chronic schizophrenic patients without TD. Significant associations were found between TD, cognitive impairment, some negative symptoms, and formal thought disorder. These associations were independent of other illness and treatment variables. The severity of TD correlated significantly with that of cognitive impairment.


2019 ◽  
Vol 7 (12) ◽  
pp. 1957-1961
Author(s):  
Deasy Hendriati ◽  
Elemeida Effendy ◽  
Mustafa Mahfud Amin ◽  
Vita Camellia ◽  
Muhammad Surya Husada

BACKGROUND: Schizophrenia is a severe mental disorder that is multi-causative and multi-factor, generally affecting about 1% of the population. The elevation level of brain-derived neurotrophic factor (BDNF) offers several protections from other neurodegenerative processes that occur in schizophrenia since this deficit of neurotrophic factors can contribute to changes in brain structure and function that underlie the schizophrenia psychopathology.AIM: To analyse the correlation between BDNF serum levels and symptom severity by using the Positive and Negative Syndrome Scale (PANSS) instrument in Bataknese male patients with schizophreniaMETHODS: This study was a correlative analytical study with a cross-sectional approach using the Positive and Negative Syndrome Scale (PANSS) instrument to assess symptom severity with 60 subjects of Bataknese male patients with chronic schizophrenia. Moreover, this research was conducted at the Psychiatric Hospital of Prof. Dr M. Ildrem Medan, Indonesia. BDNF serum was analysed with the Quantitative sandwich enzyme immunoassay technique by via Quantikine ELISA Human CXCL8/IL-8 HS. Also, the data analysis was performed through Spearman's correlative bivariate analytics using SPSS software.RESULTS: A negative correlation between the BDNF serum level and the negative scale PANSS score in men with schizophrenia (r = -0.820, p < 0.001) was found. Moreover, there is a negative correlation between BDNF serum levels and PANSS total scores in men with schizophrenia (r = -0.648, p < 0.001)CONCLUSION: BDNF serum level in Bataknese male patients with schizophrenia has a relationship that affects the severity of symptoms in schizophrenic patients, especially for negative symptoms.


2007 ◽  
Vol 32 (4) ◽  
pp. 385-391 ◽  
Author(s):  
Young-Hoon Ko ◽  
Sung-Won Jung ◽  
Sook-Haeng Joe ◽  
Chang-Hyun Lee ◽  
Hyun-Gang Jung ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. e30937 ◽  
Author(s):  
Xiang Yang Zhang ◽  
Jun Liang ◽  
Da Chun Chen ◽  
Mei Hong Xiu ◽  
Jincai He ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document